e-ISSN: Pending
Negative / Null Result ReportOpen accessPublic aspects of medicine

Can Prostate Specific Antigen Be Used as New Biomarker for Early Diagnosis of Breast Cancer?

Seyed Mostafa Shiryazdi; Mohammad Dehestani; Mohammad forat yazdi; Hamid Reza Soltani Gerdfaramarzi; Mansour Moghimi · 2015 · Journal of Community Health Research

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Introduction: As a glycoprotein, Plasma Prostate-Specific Antigen (PSA) is mainly produced by prostate epithelial cells and is used as a major diagnostic tool for prostate cancer. A group of researchers relate the elevated number of estrogen receptors in breast cancer samples to the over-production of PSA in this type of cancer. Therefore, the present study aimed to determine the participants' plasma PSA level as a new biomarker for the primary diagnosis of breast cancer. Methods: Employing a historical cohort design, this study was conducted on 95 patients suffering from breast masses. The pa

Abstract by Seyed Mostafa Shiryazdi; Mohammad Dehestani; Mohammad forat yazdi; Hamid Reza Soltani Gerdfaramarzi; Mansour Moghimi, Journal of Community Health Research (2015) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ